Upfront autologous hematopoietic stem-cell transplantation improves overall survival in comparison with bortezomib-based intensification therapy in newly diagnosed multiple myeloma: long-term follow-up analysis of the Randomized Phase 3 EMN02/HO95 Study
Upfront autologous hematopoietic stem-cell transplantation improves overall survival in comparison with bortezomib-based intensification therapy in newly diagnosed multiple myeloma: long-term follow-up analysis of the Randomized Phase 3 EMN02/HO95 Study
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2020
Συγγραφείς:
Cavo, Michele Gay, Francesca Beksac, Meral Dimopoulos, Meletios A Pantani, Lucia Petrucci, Maria Teresa Dozza, Luca Van der Holt, Bronno Zweegman, Sonja Zamagni, Elena others
